DARTMOUTH-HITCHCOCK MEDICAL CENTER

🇺🇸United States

Country: 🇺🇸United States

Ownership: Private, Subsidiary

Established: 1983-01-01

Employees: 10K

Market Cap: -

Website: http://www.dartmouth-hitchcock.org

Clinical Trials

Exploratory Study of the Modulation of the Immune System by VEGF Blockade in Patients With Glioblastoma Multiforme (GBM)

Early Phase 1

Completed

Conditions: Glioblastoma Multiforme

Interventions: Drug: Bevacizumab

First Posted Date: 2010-03-24

Last Posted Date: 2018-05-25

Lead Sponsor: Dartmouth-Hitchcock Medical Center

Target Recruit Count: 13

Registration Number: NCT01091792

Locations: 🇺🇸
Dartmouth Hithcock Medcial Center, Lebanon, New Hampshire, United States

Phyllodes Tumor Partial Breast Radiation Study

Not Applicable

Terminated

Conditions: Phyllodes Tumor

Interventions: Radiation: Partial breast radiation after lumpectomy

First Posted Date: 2010-03-18

Last Posted Date: 2023-07-25

Lead Sponsor: Dartmouth-Hitchcock Medical Center

Target Recruit Count: 11

Registration Number: NCT01089374

Locations: 🇺🇸
Dartmouth-Hitchcock Medical Center, Lebanon, New Hampshire, United States

Immune Status in Solid Organ Transplantation

Completed

Conditions: Organ Transplants

First Posted Date: 2010-02-18

Last Posted Date: 2013-02-05

Lead Sponsor: Dartmouth-Hitchcock Medical Center

Target Recruit Count: 20

Registration Number: NCT01070901

Locations: 🇺🇸
Dartmouth-Hitchcock Medical Center, Lebanon, New Hampshire, United States

Protocol to Obtain Blood for Discovery of Novel Biomarkers and Potential Therapeutic Targets in Chronic Lymphocytic Leukemia

Withdrawn

Conditions: Chronic Lymphocytic Leukemia

Interventions: Other: No Intervention

First Posted Date: 2010-02-17

Last Posted Date: 2018-03-19

Lead Sponsor: Dartmouth-Hitchcock Medical Center

Registration Number: NCT01069432

Locations: 🇺🇸
Dartmouth-Hitchcock Medical Center, Lebanon, New Hampshire, United States

Digital Breast Tomosynthesis Versus Contrast Enhanced Magnetic Resonance Imaging (MRI) for Breast Cancer Staging

Completed

Conditions: Invasive Breast Cancer
Ductal Carcinoma In Situ

First Posted Date: 2010-02-02

Last Posted Date: 2017-02-23

Lead Sponsor: Dartmouth-Hitchcock Medical Center

Target Recruit Count: 51

Registration Number: NCT01060085

Locations: 🇺🇸
Dartmouth-Hitchcock Medical Center, Lebanon, New Hampshire, United States

Evaluation of Body-worn Multimodal Hand Hygiene System. Impact on Health-Care Associated Infections

Completed

Conditions: Nosocomial Infection

Interventions: Device: Body worn alcohol gel dispenser
Drug: 62% ethanol based hand cleanser
Behavioral: Educational component with regard to teaching CDC guidelines
Behavioral: Provider and group feedback

First Posted Date: 2010-01-15

Last Posted Date: 2011-06-23

Lead Sponsor: Dartmouth-Hitchcock Medical Center

Target Recruit Count: 2954

Registration Number: NCT01050608

Locations: 🇺🇸
Dartmouth-HItchcock Medical Center, Lebanon, New Hampshire, United States

Remote Manipulation of a Capsule Endoscope

Completed

Conditions: Healthy

First Posted Date: 2010-01-08

Last Posted Date: 2010-01-08

Lead Sponsor: Dartmouth-Hitchcock Medical Center

Target Recruit Count: 1

Registration Number: NCT01044797

Plastic vs. Covered Metal vs. Uncovered Metal Biliary Stents for the Management of Malignant Biliary Obstruction

Not Applicable

Completed

Conditions: Pancreatic Cancer

Interventions: Device: Biliary stent placement

First Posted Date: 2009-12-24

Last Posted Date: 2016-06-23

Lead Sponsor: Dartmouth-Hitchcock Medical Center

Target Recruit Count: 94

Registration Number: NCT01038713

Locations: 🇺🇸
Dartmouth-Hitchcock Medical Center, Lebanon, New Hampshire, United States

Bevacizumab (Avastin) in Unresectable/Recurrent Hemangioblastoma From Von-Hippel-Lindau Disease

Early Phase 1

Terminated

Conditions: Hemangioblastomas
Von Hippel Lindau Disease

First Posted Date: 2009-11-18

Last Posted Date: 2012-05-11

Lead Sponsor: Dartmouth-Hitchcock Medical Center

Target Recruit Count: 1

Registration Number: NCT01015300

Locations: 🇺🇸
Dartmouth Hitchcock Medical Center, Lebanon, New Hampshire, United States

Apremilast Therapy for Acute Gouty Arthritis

Phase 2

Withdrawn

Conditions: Acute Gout

Interventions: Drug: indomethacin SR
Drug: apremilast

First Posted Date: 2009-10-19

Last Posted Date: 2018-04-02

Lead Sponsor: Dartmouth-Hitchcock Medical Center

Registration Number: NCT00997581

Locations: 🇺🇸
Dartmouth-Hitchcock Medical Center, Lebanon, New Hampshire, United States

© Copyright 2024. All Rights Reserved by MedPath

Home Terms & Conditions Privacy Policy